NCT04418089View on ClinicalTrials.gov

Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

May 20, 2019

Study Completion Date

September 5, 2019

Conditions
Breast CancerChemotherapy Effect
Interventions
DRUG

Simvastatin 40mg

The administration of Simvastatin 40 mg in addition to neoadjuvant chemoterapy CAF

DRUG

Placebo oral capsule

The administration of Placebo capsule 40 mg in addition to neoadjuvant chemoterapy CAF

Trial Locations (1)

10430

Faculty of Medicine, Universitas Indonesia, Jakarta Pusat

All Listed Sponsors
lead

Indonesia University

OTHER

NCT04418089 - Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter